vegf-tki therapy in first-line mrcc
Published 4 years ago • 182 plays • Length 4:27Download video MP4
Download video MP3
Similar videos
-
5:01
vegf tki therapy after i/o in mrcc
-
8:07
vegf tki immunotherapy combinations for mrcc
-
3:15
tki/i-o therapy in mrcc
-
8:03
progress in first-line mrcc
-
5:11
selecting immunotherapy versus vegf tki for mrcc
-
7:43
mrcc: resistance to vegf and i/o
-
5:15
favorable-risk rcc: frontline vegf tki/io combinations
-
1:31
toxicities associated with vegf tkis and checkpoint inhibitors in mrcc
-
9:05
mrcc: when is tki/i-o combination therapy appropriate?
-
4:53
emerging tki/i-o options in mrcc
-
7:55
mrcc: identifying and managing aes in tkis and io therapy
-
4:09
favorable-risk rcc: options for vegf tki monotherapy
-
4:47
imdc criteria and targeted therapy in mrcc
-
4:25
first-line therapy for renal cell carcinoma
-
2:46
io-io vs. io-vegf inhibitor therapy for mrcc
-
9:52
factors in selecting immunotherapy or tki inhibition
-
1:54
dr. figlin on tki therapy options in renal cell carcinoma
-
5:10
therapeutic sequencing in mrcc
-
6:30
second-line therapy after i/o in mrcc